Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · JUBLINGREA

JUBLINGREA

CommoditiesChemicals & Petrochemicals₹9233 cr market cap
₹573.70 ▼ -2.24% today As of 19 Nov 2026
52-week low ₹541.3052-week high ₹763.80

-23.2% from the 52-week high · +8.4% above the low

Jubilant Ingrevia Ltd. manufactures chemical products. The company is headquartered in Noida, Uttar Pradesh and currently employs 2,293 full-time employees. The company went IPO on 2021-03-19. The firm's segments include Speciality Chemicals, Nutrition and Health Solutions, and Chemical Intermediates. The Speciality Chemicals segment includes pyridine and picolines, fine chemicals, agro chemicals, and custom development and manufacturing organization. The Nutrition and Health Solutions segment includes nutrition and health ingredients, and animal and human nutrition health solutions. The Chemical Intermediates segment includes acetyls and speciality ethanol. Its agro chemicals business is focused on agro intermediates and agro actives, including insecticides, herbicides and fungicides. Its range of products includes nutritional ingredients, such as vitamin B3, vitamin B4, picolinates and premix formulations for both animal and human nutrition. The firm serves various industries, such as pharmaceutical, nutrition, agrochemical, consumer and industrial customers.

The short version. JUBLINGREA reported revenue of ₹1,394 crore for Sep 2026, up 24.4% from a year earlier. Net profit was ₹111 crore (up 60.9% year on year). Return on equity was 8.9% in Mar 2026. Promoter holding was 45.23% in Sep 2026, down 6.25 points over 8 quarters.

1 · The price

How has the stock traded?

JUBLINGREA trades 23.2% below its 52-week high and 8.4% above its 52-week low.

Change over period: —

1M-5.9%
3M-17.2%
6M-20.2%
1Y-16.9%

2 · The business

Is it growing?

Sales, year on year+24.4%

Sep 2026 revenue of ₹1,394 cr.

Profit, year on year+60.9%

Sep 2026 net profit of ₹111 cr.

Net margin8.0%

1.8 pts higher than a year earlier.

3-year growth-3.3% profit

Revenue compounded at -2.7% over the same 3 years.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue13941300117910511121103810511057
Net profit111106864769757469
Net margin %8.08.17.34.56.27.27.06.6
EPS (₹)7.06.645.432.944.364.714.654.36

Annual

FY2026FY2025FY2024FY2023FY2022FY2021
Revenue43884178413647734949684
Net profit27825118330847754
Net margin %6.36.04.46.49.67.9
EPS (₹)17.4515.7711.4819.3129.933.41

3 · The quality

How well does it turn capital into profit?

Return on equity was 8.9% in Mar 2026; debt to equity is 0.25.

Profitability · 4 years

Returns and margins

Mar 2026Mar 2025Mar 2024Mar 2023
Return on equity %8.98.66.711.5
Return on capital %10.811.09.314.9
EBITDA margin %13.413.210.912.1
Net margin %6.36.04.46.4

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR-2.7%45.2%
Profit CAGR-3.3%38.6%
Debt to equity0.25
Interest cover8.5x
Current ratio1.29
P/E ratio26.7

4 · The owners

Who holds it, and are they adding?

Promoter holding45.23%

Down 6.25 pts over 8 quarters.

Foreign institutions6.94%

Up 0.05 pts over 8 quarters.

Domestic institutions25.17%

Up 9.18 pts over 8 quarters.

Mutual fund schemes78

+15 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter51.4851.4845.2345.2345.2345.2345.2345.23-6.25
FII6.897.126.965.966.156.496.496.94+0.05
DII15.9915.9221.823.0424.024.7624.9825.17+9.18
Public24.924.7625.2924.9323.8122.5222.2921.69-3.21

Mutual fund holdings · Oct 2026

78 schemes hold this stock

63 the month before.

  • Old Bridge Flexi Cap Fund2.68% of NAV
  • DSP Small Cap Fund1.66% of NAV
  • Bandhan Innovation Fund1.43% of NAV
  • Groww Nifty Chemicals ETF1.41% of NAV
  • Kotak Nifty Chemicals ETF1.41% of NAV
  • Invesco India Nifty Chemical Index Fund1.38% of NAV
  • Unifi Flexi Cap Fund1.32% of NAV
  • UTI Small Cap Fund1.31% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for JUBLINGREA are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about JUBLINGREA

What is the JUBLINGREA share price?

JUBLINGREA (JUBLINGREA) last closed at ₹573.70, down 2.24% on the day. Its 52-week range is ₹541.30 to ₹763.80.

What is the market cap of JUBLINGREA?

JUBLINGREA has a market capitalisation of about ₹9,233 crore. Its price-to-earnings ratio is 26.7.

How are JUBLINGREA's latest results?

JUBLINGREA reported revenue of ₹1,394 crore for Sep 2026, up 24.4% from a year earlier. Net profit was ₹111 crore (up 60.9% year on year). Return on equity was 8.9% in Mar 2026. Promoter holding was 45.23% in Sep 2026, down 6.25 points over 8 quarters.

Who owns JUBLINGREA?

As of Sep 2026, shareholding was: Promoter 45.23%, FII 6.94%, DII 25.17%, Public 21.69%.

How many mutual funds hold JUBLINGREA?

78 mutual fund schemes held JUBLINGREA in October 2026. That compares with 63 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 10 Feb 2026 · Interim Dividend - Rs. 2.5
  • 25 Jul 2025 · Final Dividend - Rs. 2.5
  • 03 Feb 2025 · Interim Dividend - Rs. 2.5
  • 02 Aug 2024 · Final Dividend - Rs. 2.5
  • 09 Feb 2024 · Interim Dividend - Rs. 2.5
  • 10 Aug 2023 · Final Dividend - Rs. 2.5

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.